![](https://cdn.zonebourse.com/static/images/5xxWarn.png)
- We are working hard to come back as soon as possible.
- Nous travaillons dur pour revenir au plus vite.
- Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
- Estamos trabajando duro para volver lo antes posible.
- Stiamo lavorando sodo per tornare il prima possibile.
- Wij werken hard om zo snel mogelijk weer terug te zijn.
![Kris Sterkens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kris Sterkens
Algemeen Directeur bij Janssen Pharmaceutica NV
Profiel
Kris Sterkens is associated with Janssen Pharmaceutica NV and J.C.
General Service BV as Managing Director & Director since 2020.
He is also a Director at Johnson & Johnson Foundation Scotland.
Actieve functies van Kris Sterkens
Bedrijven | Functie | Begin |
---|---|---|
Johnson & Johnson Foundation Scotland
![]() Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Directeur/Bestuurslid | - |
J.C. General Service BV
![]() J.C. General Service BV MiscellaneousMiscellaneous Part of Johnson & Johnson, J.C. General Service BV offers business services such as bondspersons, drafting services, lecture bureaus and notaries. The company is based in Beerse, Belgium. The Belgian company was founded in 2000. Kris Sterkens has been the CEO of the company since 2020. | Algemeen Directeur | 01-04-2020 |
Janssen Pharmaceutica NV
![]() Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Algemeen Directeur | 01-04-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Johnson & Johnson Foundation Scotland
![]() Johnson & Johnson Foundation Scotland Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Foundation Scotland was founded in 2007. The British company's description is unrelated to their actual business. | Commercial Services |
J.C. General Service BV
![]() J.C. General Service BV MiscellaneousMiscellaneous Part of Johnson & Johnson, J.C. General Service BV offers business services such as bondspersons, drafting services, lecture bureaus and notaries. The company is based in Beerse, Belgium. The Belgian company was founded in 2000. Kris Sterkens has been the CEO of the company since 2020. | Miscellaneous |
Janssen Pharmaceutica NV
![]() Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |